You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023414018
Dec 202311208
Jan 20247303
Feb 20249804
Mar 202466012
Apr 202410404
May 20244406
Jun 20245706
Jul 20248408
Aug 20246807
Sep 20249708
Oct 2024106024
Nov 2024860113
Dec 202464027
Jan 20256607
Feb 20251808
Mar 20250017
Apr 2025004
May 2025006
Jun 2025107
Total15580297